SCHEMBL6198600

SCHEMBL6198600

O=C(Nc1cccc(O)c1)c1n[nH]c2c1CCc1ccccc1-2

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.64
RAB9A P51151 6/20 0.64
MAPT P10636 6/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
TP53 P04637 3/20 0.64
GAA P10253 1/20 0.64
NFKB1 P19838 1/20 0.64
STAT3 P40763 1/20 0.64
STAT1 P42224 1/20 0.64
NFKB2 Q00653 1/20 0.64
RELA Q04206 1/20 0.64
HTT P42858 1/20 0.46
LMNA P02545 3/20 0.44
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
MAPK1 P28482 1/20 0.41
MAPK14 Q16539 1/20 0.41
USP2 O75604 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAP4K1 Q92918 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6195935 0.87 RAB9A (0.49) NPC1RAB9AMAPTSMN1; SMN2TP53
SCHEMBL2187619 0.82 RAB9A (0.48) NPC1RAB9AMAPTSMN1; SMN2TP53
SCHEMBL6681499 0.78 RAB9A (0.47) NPC1RAB9AMAPTSMN1; SMN2TP53
SCHEMBL6632697 0.77 RAB9A (0.48) NPC1RAB9AMAPTSMN1; SMN2TP53
SCHEMBL3206132 0.75 GSR (0.53) NPC1RAB9AKMT2AALDH1A1
SCHEMBL1160454 0.74 NPC1 (0.49) NPC1RAB9AMAPTSMN1; SMN2TP53
SCHEMBL10187028 0.74 SMN1; SMN2 (0.52) NPC1RAB9AMAPTSMN1; SMN2TP53
SCHEMBL6617104 0.73 PKM (0.47) NPC1RAB9AMAPTKMT2A
SCHEMBL21909759 0.73 RAB9A (0.52) NPC1RAB9AMAPTSMN1; SMN2TP53
SCHEMBL21376322 0.72 RAB9A (0.46) NPC1RAB9AMAPTSMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501805-A1 SUBSTITUTED PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2005-02-02 EP disclosed
WO-2003095430-A1 SUBSTITUTED PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2003-11-20 WO disclosed